AstraZeneca announced plans to acquire Fusion Pharmaceuticals for up to $2.4 billion on Tuesday morning, marking its latest deal focused on opportunities in the radiopharma space.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,